L-Carnitine Improves the Asthma Control in Children with Moderate Persistent Asthma

Table 1

Demographic data and associated comorbidities in patients and control groups.

	Asthmatic (𝑛=50)	Control (𝑛=50)	t	𝑃
Age	9±2	9.14±2	0.27	>0.05
BMI	19±2	18.5±1.9	1.43	>0.05
M/F	1.1 : 1	01 : 01.1
Age at diagnosis	3±0.90	—	—	—
Urban/rural	28 : 22 (1.27 : 1)	27 : 23 (1.17 : 1)
Associated nasal allergy	27 (54%)	2 (4%)	—	<0.001*
Atopic dermatitis	17 (34%)	5 (10%)		<0.001*
Immediate family history of asthma	18 (36%)	1 (2%)	—	<0.001*
Smoking parents	1 (2%)	7 (14%)

(*) 𝑃<0.05 is significant.
There was no significant difference in age and BMI between asthmatic children and the controls while there was significant increase in the incidence of associated nasal allergy, atopic dermatitis, and family history of asthma in asthmatic children than in the control group. On the other hand the incidence of smoking parents was higher in control group than in the asthmatic group.